,52 The importance of IDH1/2 mutations in glioma is reflected by the fact that, since 2016, they have featured as diagnostic criteria in the World Health Organization’s (WHO) categorization of central nervous system (CNS) tumors.53 The gene discussed is IDH1; the disease is central nervous system neoplasm.